Oct 27, 2026Journal ArticleMixed Models, Not Mixed Messaging: Reply to Haddad, et al.Written by 2 Roon authors & 2 others Via Clinical Infectious Diseases
Jan 13, 2026Journal ArticleEmergence of a novel genotype of extensively drug-resistant Shigella sonnei carrying blaDHA-1 in diverse patient populations, Los Angeles, 2024-2025.Written by 1 Roon author & 5 others Via Antimicrobial Stewardship & Healthcare Epidemiology
ResearchIntegrating long-acting injectable cabotegravir for HIV prevention into the Brazilian public health system (ImPrEP CAB Brasil): a hybrid type-2 implementation-effectiveness cohort study
Feb 26, 2026Original ArticleTecovirimat for the Treatment of MpoxWritten by 2 Roon authors & 25 others Via The New England Journal of Medicine
ResearchUse of DNA profiling to resolve HIV status in a person using injectable cabotegravir for HIV pre-exposure prophylaxis
Feb 25, 2026Journal ArticleCabotegravir Maintains Protective Efficacy in the Setting of Bacterial Sexually Transmitted Infections: A Secondary Analysis of HPTN 083.Written by 1 Roon author & 17 others Via Clinical Infectious Diseases
ResearchEstimation of Prevention-Effective CAB-LA Concentrations Among Men Who Have Sex With Men (MSM) and Transgender Women (TGW) in HPTN 083
Feb 26, 2026Original ArticleCabotegravir plus Rilpivirine for Persons with HIV and Adherence ChallengesWritten by 1 Roon author & 35 others Via The New England Journal of Medicine
Sep 2, 2026Journal ArticleSafety and Tolerability of Oral Islatravir Once Monthly as Pre-exposure Prophylaxis in Cisgender Men and Transgender Women Who Have an Elevated Likelihood of HIV-1 Exposure: Results From the IMPOWER-24 Randomized Phase 3 Study.Written by 1 Roon author & 36 others Via Clinical Infectious Diseases
Jul 23, 2026Journal ArticleProviding the Best Infectious Diseases and Primary Care to Our Patients With HIV: Time for Delivery Models to Evolve.Written by 2 Roon authors & 1 other Via Clinical Infectious Diseases
ResearchRapid diagnostic tests, laboratory-based immunoassay and nucleic acid testing strategies for long-acting injectable pre-exposure prophylaxis: A systematic review and meta-analysis
Oct 28, 2026Journal ArticleProspective HIV RNA Screening With Long-acting Cabotegravir Pre-exposure Prophylaxis in HPTN 083.Written by 1 Roon author & 23 others Via Clinical Infectious Diseases
May 14, 2026CorrespondenceCabotegravir plus Rilpivirine for Persons with HIV and Adherence ChallengesVia The New England Journal of Medicine
ResearchPrEP as a "Hidden Message": The Impact of Partner Dynamics on Oral PrEP Adherence Among Cisgender Women in Serodiscordant Relationships